What is Trident Texofab share price return in the past 10 years?

Data is not available for this company

Trident Texofab Ltd - Stock Valuation and Financial Performance

Name: Trident Texofab
Brand: Trident Texofab

BSE: 540726 | NSE: | Textile | Small Cap

Place order

Trident Texofab Share Price

₹49.44 -0.43 -0.86%
as on 19-Apr'24 16:01

DeciZen - make an informed investing decision on Trident Texofab

Based on:

Data

M-Cap below 100cr DeciZen not available

Trident Texofab stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

39.99

Market Cap:

49.5 Cr.

52-wk low:

45.8

52-wk high:

76.1

Is Trident Texofab Ltd an attractive stock to invest in?

1. Is Trident Texofab Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Trident Texofab Ltd is a below average quality company.

2. Is Trident Texofab Ltd undervalued or overvalued?

The key valuation ratios of Trident Texofab Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Trident Texofab Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Trident Texofab Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Trident Texofab:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
ROCE % ⓘ	9.6%	8.6%	8.9%	10.2%	10.3%	9.1%	9.4%	6%	6.4%	10%	-
Value Creation Index ⓘ	-0.3	-0.4	-0.4	-0.3	-0.3	-0.4	-0.3	-0.6	-0.6	-0.3	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	60.5	62.6	66	76	85.5	86.9	91	49.9	84.3	96.4	94
Sales YoY Gr.	-	3.5%	5.5%	15.1%	12.5%	1.7%	4.7%	-45.1%	68.9%	14.3%	-
Adj EPS ⓘ	3.9	2.5	2.6	4	0.6	1.2	1	0.3	0.9	2.3	1.2
YoY Gr.	-	-34.5%	1.2%	57%	-84.1%	90.6%	-21.3%	-69.8%	220.7%	146.2%	-
BVPS (₹) ⓘ	40.6	43.1	43.5	47.6	8.6	11	11.8	11.9	12.8	15.1	16.2
Adj Net Profit ⓘ	0.2	0.2	0.2	0.3	0.6	1.2	0.9	0.3	0.9	2.3	1
Cash Flow from Ops. ⓘ	-0.6	0	0.7	0.1	-2.5	-2.8	-2.9	2	1.4	5.9	-
Debt/CF from Ops. ⓘ	-13.4	-128.8	4.3	41.1	-2.1	-5.4	-7.8	15.9	25.6	5.9	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	5.3%	2.4%	1.9%	14.3%
Adj EPS ⓘ	-5.6%	29%	33.6%	146.2%
BVPSⓘ	-10.4%	11.8%	8.5%	17.2%
Share Price	-	4.1%	25.9%	-22.8%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
Return on Equity % ⓘ	10	6.9	5.9	8.8	10.2	12.2	8.2	2.5	7.5	16.4	7.9
Op. Profit Mgn % ⓘ	2	1.9	1.5	1.5	1.7	2.8	5.3	5.8	5.7	6.6	5.5
Net Profit Mgn % ⓘ	0.4	0.3	0.3	0.4	0.7	1.4	1	0.6	1.1	2.4	1.3
Debt to Equity ⓘ	3.2	1.2	0.9	1.4	0.6	1.4	1.9	2.6	2.8	2.3	-
Working Cap Days ⓘ	122	147	173	136	126	152	147	304	185	176	95
Cash Conv. Cycle ⓘ	27	27	22	3	18	29	61	136	98	98	17

Recent Performance Summary

Net Profit is growing at healthy rate in last 3 years 33.61%

Debt to equity has declined versus last 3 years average to 2.29

Return on Equity has declined versus last 3 years average to 7.90%

Sales growth has been subdued in last 3 years 1.94%

Sales growth is not so good in last 4 quarters at -3.16%

Latest Financials - Trident Texofab Ltd.

	Standalone	Consolidated
TTM EPS (₹)	1.2	-
TTM Sales (₹ Cr.)	93.6	-
BVPS (₹.) ⓘ	16.2	-
Reserves (₹ Cr.) ⓘ	6	-
P/BV ⓘ	3.03	-
PE ⓘ	39.99	-

From the Market
52 Week Low / High (₹)	45.75 / 76.10
All Time Low / High (₹)	13.33 / 206.00
Market Cap (₹ Cr.)	49.5
Equity (₹ Cr.)	10.1
Face Value (₹)	10
Industry PE ⓘ	28.4

Management X-Ray of Trident Texofab:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Trident Texofab

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Trident Texofab

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Sales	60.46	62.56	65.98	75.95	85.46	86.90	90.96	49.91	84.29	96.36
Operating Expenses ⓘ	59.23	61.38	64.99	74.80	84.01	84.50	86.14	47.03	79.50	90.05
Manufacturing Costs	0	0	0	0.32	0.42	0.70	2.41	0.91	1.56	3
Material Costs	57.61	59.32	62.82	72.38	81.97	79.51	78.78	42.06	72.26	80.39
Employee Cost	0.79	0.87	0.90	0.66	0.67	1.59	2.11	1.71	2.06	2.40
Other Costs ⓘ	0.82	1.19	1.28	1.44	0.95	2.70	2.83	2.35	3.63	4.26
Operating Profit ⓘ	1.23	1.18	0.99	1.15	1.45	2.40	4.83	2.88	4.79	6.31
Operating Profit Margin (%)	2.0%	1.9%	1.5%	1.5%	1.7%	2.8%	5.3%	5.8%	5.7%	6.5%
Other Income ⓘ	0.06	0.10	0.05	0.24	0.48	0.32	0.42	1.85	0.74	1.90
Interest ⓘ	0.88	0.80	0.60	0.68	0.77	0.86	2.71	2.85	2.83	3.71
Depreciation ⓘ	0.11	0.19	0.14	0.13	0.13	0.30	1.01	1.02	1.47	1.64
Exceptional Items ⓘ	-0.01	-0.03	-0.21	-0.02	0	0.14	0	0.05	0.04	-0.13
Profit Before Tax ⓘ	0.29	0.25	0.09	0.56	1.04	1.69	1.53	0.90	1.27	2.73
Tax ⓘ	0.06	0.07	0.03	0.23	0.29	0.42	0.63	0.55	0.29	0.51
Profit After Tax	0.22	0.18	0.06	0.33	0.75	1.27	0.90	0.35	0.98	2.22
PAT Margin (%)	0.4%	0.3%	0.1%	0.4%	0.9%	1.5%	1.0%	0.7%	1.2%	2.3%
Adjusted EPS (₹)	0.5	0.3	0.1	0.5	0.8	1.3	0.9	0.4	1.0	2.2
Dividend Payout Ratio (%)	0%	0%	0%	0%	53%	31%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Equity and Liabilities
Shareholders Fund	2.41	3.43	3.46	3.79	8.26	11	11.62	11.98	12.96	15.18
Share Capital ⓘ	0.25	0.33	0.33	0.33	4	4.20	4.20	10.07	10.07	10.07
Reserves ⓘ	2.16	3.10	3.13	3.46	4.27	6.80	7.43	1.91	2.89	5.11
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	7.26	3.56	2.98	5.18	4.17	12.85	20.37	29.15	33.40	31.72
Long Term Debt	2.84	1.14	0.51	5.18	4.17	9.25	10.55	19.19	20.27	18.58
Short Term Debt	4.42	2.42	2.47	0	0	3.60	9.81	9.96	13.13	13.14
Trade Payables	16.42	20.58	30.80	14.84	30.31	19.39	16.03	16.22	11.39	17.62
Others Liabilities ⓘ	0.72	0.84	0.74	0.67	2.20	3.81	7.66	10.43	13.24	12.79
Total Liabilities ⓘ	26.80	28.42	37.99	24.48	44.94	47.04	55.68	67.77	70.99	77.31
Fixed Assets
Gross Block	3	2.06	1.72	1.73	2.17	3.27	14.18	16.75	25.43	28.56
Accumulated Depreciation	0.22	0.36	0.39	0.48	0.61	0.91	1.70	2.54	3.72	5.23
Net Fixed Assetsⓘ	2.78	1.70	1.33	1.25	1.56	2.36	12.48	14.21	21.71	23.33
CWIP ⓘ	0	0	0	0	0	6.39	0.30	8.89	3.62	0
Investmentsⓘ	0	0.04	0.33	0.82	2.65	1.42	1.12	2.48	2.06	3.64
Inventories	4.96	6.62	9.38	2.31	5.07	3.93	10.11	8.01	7.27	10.64
Trade Receivables	17.28	18.90	26.03	15.40	32.13	29.40	26.43	30.28	30.85	33.87
Cash Equivalents	0.11	0.22	0.16	1.86	0.23	0.39	0.08	0.03	0.04	0.06
Others Assetsⓘ	1.68	0.95	0.76	2.85	3.29	3.16	5.15	3.86	5.43	5.76
Total Assets ⓘ	26.80	28.42	37.99	24.48	44.94	47.04	55.68	67.77	70.99	77.31

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Cash Flow From Operating Activity ⓘ	-0.57	-0.03	0.70	0.13	-2.45	-2.75	-2.85	1.96	1.39	5.85
PBT ⓘ	0.29	0.25	0.09	0.56	1.04	1.69	1.53	0.90	1.27	2.73
Adjustment ⓘ	0.05	0.10	0.08	0.12	0.13	1.24	3.68	2.92	4.64	4.33
Changes in Working Capital ⓘ	-0.84	-0.3	0.61	-0.38	-3.19	-4.94	-7.56	-1.63	-4.52	-1.07
Tax Paid ⓘ	-0.07	-0.08	-0.08	-0.17	-0.41	-0.74	-0.50	-0.23	0	-0.13
Cash Flow From Investing Activity ⓘ	-0.38	0.99	-0.10	-0.54	-2.27	-6.61	-2.41	-10.19	-4.38	0.37
Capex	-0.39	0.88	0.24	-0.05	-0.44	-7.60	-1.63	-9.92	-3.80	-0.22
Net Investments	0	0	-0.32	-0.49	-1.83	0.99	-0.83	-0.09	-0.57	-0.10
Others ⓘ	0.01	0.11	-0.02	0	0	0	0.05	-0.19	-0.01	0.69
Cash Flow From Financing Activityⓘ	0.84	-0.85	-0.63	2.11	3.09	9.59	4.95	8.19	2.99	-6.20
Net Proceeds from Shares ⓘ	0	0.85	0	0	4.48	2.03	0	0	0	0
Net Proceeds from Borrowing ⓘ	0.84	-1.70	-0.63	4.58	-1.02	5.08	1.94	9.19	1.49	-3.16
Interest Paid ⓘ	0	0	0	0	0	-0.86	-2.41	-2.73	-2.22	-3.39
Dividend Paid ⓘ	0	0	0	0	0	-0.08	-0.41	0	0	0
Others ⓘ	0	0	0	-2.47	-0.38	3.42	5.84	1.72	3.72	0.36
Net Cash Flow ⓘ	-0.12	0.11	-0.02	1.69	-1.62	0.22	-0.31	-0.05	0	0.02

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Ratios
ROE (%)	9.75	6.17	1.7	9.07	12.44	13.56	8.25	3.04	7.91	15.8
ROCE (%)	13.23	11.91	9.87	15.9	16.1	13.12	14.28	9.8	8.95	13.07
Asset Turnover Ratio	2.63	2.27	1.99	2.43	2.55	2	1.87	0.82	1.22	1.31
PAT to CFO Conversion(x)	-2.59	-0.17	11.67	0.39	-3.27	-2.17	-3.17	5.6	1.42	2.64
Working Capital Days
Receivable Days	86	106	124	100	98	122	106	206	132	122
Inventory Days	27	34	44	28	15	18	27	66	33	34
Payable Days	88	114	149	115	101	114	82	140	70	66

Trident Texofab Ltd Stock News

Trident Texofab Ltd FAQs

What is the share price of Trident Texofab?

Company share prices are keep on changing according to the market conditions. The closing price of Trident Texofab on 19-Apr-2024 16:01 is ₹49.44.

What is the market cap of Trident Texofab?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 19-Apr-2024 16:01 the market cap of Trident Texofab stood at ₹49.54.